Lista de obras -

AACE comprehensive diabetes management algorithm 2013.

artículo científico publicado en 2013

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

artículo científico publicado en 2017

AACE/ACE comprehensive diabetes management algorithm 2015.

artículo científico publicado en 2015

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

artículo científico publicado en 2006

ACP Diabetes Guidelines Turn Back the Clock, Conflating Good HbA1c with Hypoglycemia.

artículo científico publicado en 2018

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

artículo científico publicado en 2016

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.

artículo científico publicado en 2018

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journal

artículo científico publicado en 2017

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

artículo científico

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.

artículo científico publicado en 2017

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

artículo científico publicado en 2016

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan

artículo científico publicado en 2011

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary

artículo científico publicado en 2011

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

scientific article published on 01 May 2007

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

artículo científico publicado en 2012

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary

artículo científico publicado en 2012

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

artículo científico publicado en 2013

American Association of Clinical Endocrinologists' position statement on clinical nutrition and health promotion in endocrinology

artículo científico publicado en 2012

American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.

artículo científico publicado en 2012

American College of Endocrinology position statement on the insulin resistance syndrome.

artículo científico publicado en 2003

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

artículo científico publicado en 2015

American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.

artículo científico publicado en 2014

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease

scientific article published on September 2014

An interview with the authors of Did AIM-HIGH aim too low. Interview by Jinghong Xu.

artículo científico publicado en 2012

Approaches to treatment 2: Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines

artículo científico publicado en 2015

Bile acid sequestrants for lipid and glucose control

artículo científico publicado en 2010

Burden of Illness in Type 2 Diabetes Mellitus

scientific article published on 01 September 2018

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

artículo científico publicado en 2017

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

artículo científico publicado en 2018

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY

artículo científico publicado en 2019

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY

artículo científico publicado en 2020

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

artículo científico publicado en 2015

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

artículo científico publicado en 2016

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

artículo científico publicado en 2016

Cancer mortality and insulin glargine ⬇️

artículo científico publicado el 2 de julio de 2009

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

artículo científico publicado en 2020

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications

scientific article published on 01 September 2018

Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes

artículo científico

Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes

artículo científico publicado en 2009

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study

artículo científico publicado en 2010

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

artículo científico publicado en 2010

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

artículo científico publicado en 2019

Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids

scientific article published on 01 December 2011

Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality

artículo científico publicado en 2017

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force

artículo científico publicado en 2014

Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

artículo científico publicado en 2020

Corrections

scientific article published on 01 November 2018

DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT

artículo científico publicado en 2018

Diabetes and cancer--an AACE/ACE consensus statement

artículo científico publicado en 2013

Diabetes in youth: a dilemma of pathogenesis

artículo científico publicado en 2011

Diabetes treatment over age 65: Is worse control really better?

artículo científico publicado en 2017

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

artículo científico publicado en 2008

Did AIM-HIGH aim too low?

artículo científico publicado en 2012

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

artículo científico publicado en 2016

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study.

artículo científico publicado en 2019

EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES

artículo científico publicado en 2018

Effectiveness of primary care-relevant treatments for obesity in adults

artículo científico publicado en 2012

Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy

artículo científico publicado en 2010

Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes

scientific article published on 30 November 2018

Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?

scientific article published on 03 February 2019

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization

scientific article published on 21 September 2020

Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists

scientific article published on 01 September 2018

Good news!

artículo científico publicado en 2010

Gut hormones and the brain

artículo científico publicado en 2010

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus

scientific article published on 01 September 2018

How does CKD affect HbA1c?

artículo científico publicado en 2017

Hypoglycemia in the intensive care unit

artículo científico publicado en 2007

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes

artículo científico publicado en 2010

Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes

artículo científico publicado en 2012

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

artículo científico publicado en 2012

Insulin treatment of Type 2 diabetes: a clinical perspective ⬇️

artículo científico publicado el 25 de marzo de 2010

Introduction to the 2nd Heart in Diabetes (HiD) Meeting

scientific article published on 07 May 2019

Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US* ⬇️

artículo científico publicado el 1 de marzo de 2011

Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old?

artículo científico publicado en 2017

Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?

artículo científico

Lessons from glargine trials: what is the goal fasting glucose with basal insulin?

artículo científico publicado en 2014

Notes from the world congress on insulin resistance, diabetes, and cardiovascular disease

artículo científico publicado en 2019

Overcoming obstacles in risk factor management in type 2 diabetes mellitus

artículo científico publicado en 2011

PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.

artículo científico publicado en 2015

Paradigm Shift in the management of DM & CVD- Preventing The Next CV Event

artículo científico publicado en 2020

Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring

artículo científico

Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

scientific article published on 13 August 2018

Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes

scientific article published on 23 August 2019

Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials

artículo científico publicado en 2014

Response to Comment on Bloomgarden et al. Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old? Diabetes Care 2017;40:526-528.

artículo científico publicado en 2017

Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force

artículo científico publicado en 2007

SGLT-2 INHIBITION ADDED TO GLP-1 AGONIST THERAPY FOR TYPE 2 DIABETES: WHAT IS THE BENEFIT?

artículo científico publicado en 2015

Sodium-glucose cotransporter 2 inhibitors for macroalbuminuria: A new indication

artículo científico publicado en 2019

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

artículo científico publicado en 2009

Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management ⬇️

artículo científico publicado el 1 de septiembre de 2010

Sugar-sweetened beverages: changing the tide

scientific article published on 01 March 2013

Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

scientific article published on 03 January 2019

TRANSCULTURALIZATION RECOMMENDATIONS FOR DEVELOPING LATIN AMERICAN CLINICAL PRACTICE ALGORITHMS IN ENDOCRINOLOGY--PROCEEDINGS OF THE 2015 PAN-AMERICAN WORKSHOP BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRIN

artículo científico publicado en 2016

The Avandia debate: An unhappy conclusion ⬇️

artículo científico publicado el 1 de diciembre de 2010

The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome

artículo científico publicado en 2015

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial

artículo científico publicado en 2016

The Journal of diabetes: continuing the dialogue

artículo científico publicado en 2013

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

artículo científico publicado en 2013

The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations

artículo científico publicado en 2013

Transition from hospital to outpatient diabetes care.

artículo científico publicado en 2018

Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure

artículo científico publicado en 2020

World congress on insulin resistance, diabetes and cardiovascular disease

scientific article published on 04 July 2018

Lista de obras de

AACE comprehensive diabetes management algorithm 2013.

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

AACE/ACE comprehensive diabetes management algorithm 2015.

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations

ACP Diabetes Guidelines Turn Back the Clock, Conflating Good HbA1c with Hypoglycemia.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journal

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

American Association of Clinical Endocrinologists' position statement on clinical nutrition and health promotion in endocrinology

American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.

American College of Endocrinology position statement on the insulin resistance syndrome.

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease

An interview with the authors of Did AIM-HIGH aim too low. Interview by Jinghong Xu.

Approaches to treatment 2: Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines

Bile acid sequestrants for lipid and glucose control

Burden of Illness in Type 2 Diabetes Mellitus

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

Cancer mortality and insulin glargine ⬇️

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications

Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes

Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipids

Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force

Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Corrections

DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT

Diabetes and cancer--an AACE/ACE consensus statement

Diabetes in youth: a dilemma of pathogenesis

Diabetes treatment over age 65: Is worse control really better?

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

Did AIM-HIGH aim too low?

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study.

EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES

Effectiveness of primary care-relevant treatments for obesity in adults

Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy

Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes

Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization

Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists

Good news!

Gut hormones and the brain

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus

How does CKD affect HbA1c?

Hypoglycemia in the intensive care unit

Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes

Initial combination therapy with metformin plus colesevelam in drug-naïve Hispanic patients with early type 2 diabetes

Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Insulin treatment of Type 2 diabetes: a clinical perspective ⬇️

Introduction to the 2nd Heart in Diabetes (HiD) Meeting

Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US* ⬇️

Is HbA1c <7% a Marker of Poor Performance in Individuals >65 Years Old?

Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?

Lessons from glargine trials: what is the goal fasting glucose with basal insulin?

Notes from the world congress on insulin resistance, diabetes, and cardiovascular disease

Overcoming obstacles in risk factor management in type 2 diabetes mellitus